2',2'-DFDC,
2',2'-difluoro-2'-deoxycytidine,
2',2'-difluorodeoxycytidine,
2'-deoxy-2',2''-difluorocytidine-5'-O-monophosphate,
2'-deoxy-2'-difluorocytidine,
dFdCyd,
gemcitabine,
gemcitabine hydrochloride,
gemcitabine, (alpha-D-threo-pentofuranosyl)-isomer,
gemcitabine, (beta-D-threo-pentafuranosyl)-isomer,
gemcitabine, (D-threo-pentafuranosyl)-isomer,
Gemzar,
LY 188011,
LY-188011,
GEMCITABINE HYDROCHLORIDE,
122111-03-9,
Gemcitabine HCl,
Gemzar,
2'-Deoxy-2',2'-difluorocytidine monohydrochloride,
LY188011 hydrochloride,
Gemcitabine (Hydrochloride),
UNII-U347PV74IL,
Gemcitabine HCL (Gemzar),
C9H11F2N3O4.HCl,
Cytidine, 2'-deoxy-2',2'-difluoro-, monohydrochloride,
U347PV74IL,
2',2'-Difluoro-2'-deoxycytidine hydrochloride,
2',2'-Difluorodeoxycytidine monohydrochloride,
DSSTox_CID_27827,
DSSTox_RID_82590,
DSSTox_GSID_47849,
LY-188011,
2'-deoxy-2',2'-difluorocytidine hydrochloride,
2'-Deoxy-2',2'-difluorocytidine monohydrochloride (beta-isomer),
CHEBI:31647,
dFdC,
Dizirconium silicide,
2',2'-difluoro-2'-deoxycytidine,
2'-Deoxy-2',2'-difluorocytidine,
CAS-122111-03-9,
LY 188011 hydrochloride,
Gemcitabine hydrochloride [USAN],
NCGC00168784-01,
4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one hydrochloride,
4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one;hydrochloride,
Gemzar (TN),
Gemcitabine hydrochloride [USAN:USP],
AC1L1TUN,
Inno-D07001,
SCHEMBL4366,
CHEMBL1637,
12211-03-9,
MLS003915643,
Gemcitabine hydrochloride,(S),
DTXSID3047849,
AOB6388,
EBD6307,
EX-A837,
Gemcitabine-Hydrochloride(Gemzar),
OKKDEIYWILRZIA-OSZBKLCCSA-N,
4-Amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1H-pyrimidin-2-one hydrochloride,
ACT06731,
HY-B0003,
Tox21_112644,
AN-738,
MFCD01735988,
s1149,
Gemcitabine hydrochloride (JAN/USAN),
AKOS015999730,
Tox21_112644_1,
ACN-029559,
CS-0755,
Gemcitabine HCl (Gemzar,LY188011),
SB17338,
KS-000002I0,
NCGC00168784-03,
AS-13656,
CC-28945,
CPD000469146,
LS-59069,
SAM001246550,
SC-19019,
SMR000469146,
Gemcitabine hydrochloride, >=98% (HPLC),
AB0069148,
AX8040659,
ST2413104,
TL8000589,
FT-0626640,
2',2'-DIFLUORO-2'-DEOXYCYTIDINE HCL,
Gemcitabine Hydrochloride,Gemzar, LY-188011,
D01155,
J10060,
M-9023,
2'-deoxy-2',2'-difluorocytidine, hydrochloride,
111G039,
139306-EP2270008A1,
139306-EP2289892A1,
139306-EP2292617A1,
W-60402,
(+)-2'-Deoxy-2',2'-difluorocytidine hydrochloride,
J-700175,
Gemcitabine hydrochloride, European Pharmacopoeia (EP) Reference Standard,
Gemcitabine hydrochloride, United States Pharmacopeia (USP) Reference Standard,
(2'R,4'R,5'R)-4-Amino-1-(3,3-difluoro-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1H-pyridin-2-one hydrochloride,
4-amino-1-(3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one hydrochloride,
4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one hydrochloride,
4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one hydrochloride,
gemcitabine,
SiZr2,
DDFC,
Si-Zr2,
UNII-B76N6SBZ8R,
Zirconium silicide (Zr2Si),
C9H11F2N3O4.ClH,
CID60749,
EINECS 235-389-8,
C9-H11-F2-N3-O4.Cl-H,
LY188011,
Gemcitabine hydrochloride, 99% - 1G 1g,
A10423,
95058-81-4,